We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RGTI:NASDAQRigetti Computing, Inc. Analysis

Data as of 2026-08-02 - not real-time

$14.95

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Rigetti Computing (RGTI) is trading at $14.95, well below its 20‑day SMA of $15.34 and the 50‑day SMA of $19.15, indicating a bearish price environment. The RSI sits at 44, suggesting neutral momentum, while the MACD histogram is positive (0.14) despite the MACD line remaining under its signal, hinting at a tentative upside. Volatility is extreme at 87% over the past 30 days and beta exceeds 3.5, underscoring high market sensitivity. Fundamentally, the company reports a staggering price‑to‑book of 8.5× and price‑to‑sales of nearly 500×, with negative earnings and a forward PE of –74, flagging significant overvaluation. However, cash on hand ($418 M) dwarfs its modest debt ($6.8 M) and revenue has surged nearly 200% year‑over‑year, while a new $5 M NSF‑backed partnership with HPE and PSC adds credibility to its quantum‑HPC roadmap. The blend of soaring valuation multiples, sharp downside risk (‑77% max drawdown) and promising strategic partnerships creates a mixed picture that leans toward caution in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Current price below short‑term moving averages
  • Extreme 30‑day volatility and high beta
  • Recent partnership news providing short‑term catalyst

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Rapid revenue growth but continued operating losses
  • Massive valuation multiples relative to peers
  • Strong cash position supporting ongoing R&D

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic positioning in the nascent quantum‑computing market
  • Robust cash runway and limited debt
  • Potential upside from expanding QCaaS and quantum‑HPC collaborations

Key Metrics & Analysis

Financial Health

Revenue Growth198.90%
P/E Ratio-74.3
ROE-57.09%
ROA-12.09%
Debt/Equity1.16
P/B Ratio8.5
Op. Cash Flow$-61108000
Free Cash Flow$-6209875
Industry P/E32.8

Technical Analysis

TrendBearish
RSI44.1
Support$13.13
Resistance$18.71
MA 20$15.34
MA 50$19.15
MA 200$21.97
MACDBullish
VolumeStable
Fear & Greed Index92.88

Valuation

Target Price$29.65
Upside/Downside98.30%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.81
Volatility87.24%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.